ResearcherUniversity Hospital of GenevaNo recent work listed

Claudia Burkhardt

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5011954348. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 2

New Isotopes for the Treatment of Pancreatic Cancer in Collaboration With CERN: A Mini Review. Co-author DOI 10.3389/fmed.2021.674656 ↗
[Can the management and pronostic of pancreatic adenocarcinoma be improved ?] First author DOI 10.53738/revmed.2018.14.611.1237 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Thierry Storà · 1 shared paper, 2021 · strength 0.19
- Paper New Isotopes for the Treatment of Pancreatic Cancer in Collaboration With CERN: A Mini Review. DOI 10.3389/fmed.2021.674656 ↗
Léo Bühler · 1 shared paper, 2021 · strength 0.19
- Paper New Isotopes for the Treatment of Pancreatic Cancer in Collaboration With CERN: A Mini Review. DOI 10.3389/fmed.2021.674656 ↗
Zacharia Mbaidjol Kabra · 1 shared paper, 2018 · strength 0.08
- Paper [Can the management and pronostic of pancreatic adenocarcinoma be improved ?] DOI 10.53738/revmed.2018.14.611.1237 ↗
Philippe Morel · 1 shared paper, 2018 · strength 0.08
- Paper [Can the management and pronostic of pancreatic adenocarcinoma be improved ?] DOI 10.53738/revmed.2018.14.611.1237 ↗
Léo H. Bühler · 1 shared paper, 2018 · strength 0.08
- Paper [Can the management and pronostic of pancreatic adenocarcinoma be improved ?] DOI 10.53738/revmed.2018.14.611.1237 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.